Studies on hemolysis properties of medicalα-calcium sulfate hemihydrate

Objective:The as-providedα-calcium sulfate hemihydrate bone repair material exhibits superior degradation properties and osteogenic property to the traditional calcium sulfate bone repair materials. Its effects on the blood and the biocompatibility were studied to ensure its safety for the bone implantation application.Method: The hemolytic tests were conducted to evaluate the blood compatibility of theα-calcium sulfate hemihydrate. The extracts ofα-calcium sulfate hemihydrate with different concentration reacted with 2% rabbit red blood cell suspension. The existence and morphology of the red blood were observed through naked eye observation and microscope observation. The hemolytic ratios were calculated through the absorbances using a ultraviolet spectrophotometer.Result:It was observed by naked eye that the red blood accumulated at the bottom of the test tubes and the upper liquids were clear, colorless and transparent in the experimental sample. The microscope observation exhibited that the cells of the experimental samples had the normal morphology, no deformed and broken blood sell existed. The hemolytic ratios of the experimental sample were all less than 5%. The hemolytic ratios were increased with the increase of the concentration of the extracts. Conclusions: The hemolytic ratios of the medical -calcium sulfate hemihydrate accorded with the standard ISO/TR7405-1984(E). It could be concluded the material would not cause acute hemolysis. The osteogenic property exhibited dose dependence.

Evaluation of erastin synergized cisplatin anti-nasopharyngeal carcinoma effect with a glutathione-activated near-infrared fluorescent probe

Nasopharyngeal carcinoma(NPC),a malignant tumor originating from the nasopharynx,is one of the common malignant tumors of the head and neck.There are significant geographical differences in the incidence of nasopharyngeal carcinoma,with a high incidence in China and Southeast Asian countries.Herein,we designed and synthesized a novel near-infrared fluorescent(NIRF)probe to detect glutathione(GSH)in cellular and tumor environments using semi-naphthofluorescein(SNAFL)as the fluorescent molecular backbone and 2-fluoro-4-nitrobenzenesulfonate as the recognition moiety.Upon reaction with GSH,SNAFL-GSH emitted a fluorescence signal,and its emission wavelength at 650 nm was remarkably enhanced.The results of selectivity experiments indicated that SNAFL-GSH was able to discriminate GSH from Cys,Hcy,and H_(2) S.Moreover,SNAFL-GSH could image both endogenous and exogenous GSH and distinguish normal and cancer cells by fluorescence signal difference.At the cellular level,cisplatin(DDP)-induced ferroptosis and inhibition of proliferation of various NPC cell lines(CNE2,CNE1,5-8F cells)by erastin combined with DDP were visualized with the help of SNAFL-GSH.In a mouse tumor xenograft model,we successfully employed SNAFL-GSH for the evaluation of the efficacy of erastin combined with DDP in the treatment of NPC.More importantly,the probe could image cancerous tissue sections from NPC patients with an imaging depth of approximately 80µm.It was foreseen that SNAFL-GSH offered great potential for application in the diagnosis and evaluation of the therapeutic efficacy of NPC,and these results would also provide new ideas for the clinical treatment of NPC.